RESEARCH TRIANGLE PARK, N.C., July 02, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted five newly-hired employees stock options to purchase an aggregate of 46,850 shares, and restricted stock units (RSUs) covering an aggregate of 19,435 shares, of BioCryst common stock. The options and RSUs were granted as of June 28, 2024, as inducements material to each employee entering into employm
It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...
Key Insights BioCryst Pharmaceuticals' Annual General Meeting to take place on 12th of June Salary of US$665.6k is part...